Àΰø °¢¸· ¹× °¢¸· ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, ¿¹Ãø : À¯Çü, ÀÌ½Ä À¯Çü, Áúȯ ÀûÀÀÁõ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2025-2033³â)
Artificial Cornea and Corneal Implant Market Size, Share, Trends and Forecast by Type, Transplant Type, Disease Indication, End User, and Region, 2025-2033
»óǰÄÚµå : 1702202
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 136 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,130,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,507,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 6,884,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Àΰø °¢¸· ¹× °¢¸· ÀÓÇöõÆ® ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 4¾ï 6,885¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö 8¾ï 3,198¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, 2025³âºÎÅÍ 2033³â±îÁö 6.25%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÇöÀç ºÏ¹Ì°¡ 50.5%ÀÇ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÏ¸ç ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. °¢¸· °¨¿° ¹× ¾È°ú °ü·Ã ÁúȯÀÇ À¯º´·ü Áõ°¡, ´Ù¾çÇÑ ÀÇ·á ½Ã¼³ÀÇ °Ç¼³ Áõ°¡, °¢¸· ÀüÃþ À̽Ŀ¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

Àΰø °¢¸· ¶Ç´Â °¢¸· ÀÓÇöõÆ®´Â ¼Õ»óµÈ °¢¸·ÀÇ ÀϺθ¦ ±âÁõÀڷκÎÅÍ ¾òÀº °Ç°­ÇÏ°í ¹®Á¦°¡ ¾ø´Â °¢¸· Á¶Á÷À¸·Î ´ëüÇϱâ À§ÇØ ½ÃÇàµÇ´Â ƯÁ¤ ¼ö¼úÀ» ¸»ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¼úÀº °¢¸· Áٱ⼼Æ÷ Àüü¸¦ À̽ÄÇÏ´Â °üÅë°¢¸·¼ºÇü¼ú°ú ³»Çǰ¢¸·¼ºÇü¼ú µî ´Ù¾çÇÑ ÀÇ·á ½Ã¼ú·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. ÇÏÀ̵å·Î°ÖÀ̸ç À¯ÀüÀÚÀçÁ¶ÇÕ Äݶó°ÕÀ¸·Î Á¦Á¶µÈ ÀÓÇöõÆ®¸¦ ȯÀÚÀÇ °¢¸·À» Àý°³ÇÏ¿© »ðÀÔÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¼úÀº ÁÖ·Î °¨¿°¼º °¢¸·¿°, ¿øÃß°¢¸·, °¢¸·±Ë¾ç, ÈÄÅ©½ºµð½ºÆ®·ÎÇÇ ÁúȯÀÇ Ä¡·á¸¦ À§ÇØ ½ÃÇàµË´Ï´Ù. Àΰø °¢¸·À̳ª °¢¸· ÀÓÇöõÆ®´Â Æ®¶óÄÚ¸¶, °¨¿°¼º °¢¸·¿°, ¾È±¸ ¿Ü»ó, È­ÇÐÀû ¼Õ»ó°ú °°Àº °¢¸· ¾ÕÂÊÀÇ Áúº´À» Ä¡·áÇϱâ À§Çؼ­µµ ÇÊ¿äÇÕ´Ï´Ù. ½Ã·Â °³¼±, ÅëÁõ ¿ÏÈ­, °¢¸·ÀÇ ÀûÀýÇÑ ¸ð¾ç À¯Áö, ½É°¢ÇÑ °¨¿° ¹× ¼Õ»ó Ä¡·á¿¡ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, °¢¸· ÈäÅͳª °¢¸· ÁúȯÀ» ¾Î°í Àִ ȯÀÚÀÇ ¸¼Àº ½Ã¾ß¸¦ µÇã¾Æ ÀÏ»ó»ýȰÀ» º¸´Ù ½±°Ô ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

Àΰø °¢¸· ¹× °¢¸· ÀÓÇöõÆ® ½ÃÀå µ¿Çâ:

ÇöÀç ´ëÁßµé »çÀÌ¿¡¼­ °¢¸· °¨¿° ¹× ´« °ü·Ã ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Àΰø °¢¸· ¹× °¢¸· ÀÓÇöõÆ®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ÀÌ¿Í ´õºÒ¾î ȯÀÚ¿¡°Ô È¿°úÀûÀÎ Ä¡·á¸¦ Á¦°øÇϱâ À§ÇØ º´¿ø, ¿ä¾ç¿ø, ¾È°ú Ŭ¸®´Ð µî ´Ù¾çÇÑ ÀÇ·á ½Ã¼³ÀÇ °Ç¼³ÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå Àü¸ÁÀ» ¹à°Ô Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àå½Ã°£ ½º¸¶Æ®Æù ½Ãû, ÄÄÇ»ÅÍ ¹× ³ëÆ®ºÏ ÀÛ¾÷ µîÀ¸·Î ÀÎÇØ ÀþÀº ÃþÀÇ ½Ã·Â ÇÕº´Áõ ¹ß»ýÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î Àü ¼¼°è ³ëÀÎ Àα¸ÀÇ Áõ°¡·Î ÀÎÇÑ °¢¸· ÀüÃþ À̽Ŀ¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÈäÅÍ Çü¼ºÀ» ÇÇÇϰí ȸº¹ ±â°£À» ´ÜÃàÇÏ¸ç ºñ¿ë°ú ÀÔ¿ø ±â°£À» ÁÙÀ̱â À§ÇØ ÃÖ¼Òħ½À(MI) °¢¸· ÀÌ½Ä ¹æ¹ýÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â °í·É ȯÀÚÀÇ ´« °ü·Ã ÇÕº´ÁõÀ» Ä¡·áÇϱâ À§ÇØ °üÅë °¢¸· À̽ļú¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °¢¸· Áúȯ Ä¡·á¿¡ ÀÖ¾î »ýüÀûÇÕ¼º°ú ¸ÂÃãÇü¼ºÀÌ ¶Ù¾î³­ 3Â÷¿ø(3D) ÇÁ¸°ÆÃ Àΰø °¢¸·°ú °°Àº Çõ½ÅÀûÀ̰í È¿°úÀûÀÎ ÀÇ·áÁ¦Ç°ÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀå¿¡ ÈûÀ» ½Ç¾îÁÖ°í ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

Á¦5Àå ¼¼°èÀÇ Àΰø °¢¸· ¹× °¢¸· ÀÓÇöõÆ® ½ÃÀå

Á¦6Àå ½ÃÀå ³»¿ª : À¯Çüº°

Á¦7Àå ½ÃÀå ³»¿ª : ÀÌ½Ä À¯Çüº°

Á¦8Àå ½ÃÀå ³»¿ª : Áúȯ ÀûÀÀÁõº°

Á¦9Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ½ÃÀå ³»¿ª : Áö¿ªº°

Á¦11Àå SWOT ºÐ¼®

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå Porter's Five Forces ºÐ¼®

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global artificial cornea and corneal implant market size was valued at USD 468.85 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 831.98 Million by 2033, exhibiting a CAGR of 6.25% during 2025-2033. North America currently dominates the market with a market share of 50.5%. The growing prevalence of corneal infections and eye-associated disorders, rising construction of various healthcare facilities, and escalating demand for full-thickness corneal transplantation represent some of the key factors driving the market.

Artificial cornea and corneal implant refer to specific surgical procedures conducted to replace segments of the damaged cornea with healthy and unaffected corneal tissue obtained from a donor. They consist of a wide variety of medical procedures, such as penetrating and endothelial keratoplasty, which involves the transplantation of the entire corneal stem cells. They involve transplantation of implants that are hydrogels in nature and manufactured with recombinant collagen and inserted in a tiny incision made on the cornea of the patient. These procedures are primarily performed for the treatment of infectious keratitis, keratoconus, corneal ulcers, and Fuchs dystrophy diseases. Artificial cornea and corneal implant are also necessary for curing anterior corneal pathologies, such as trachoma, infectious keratitis, ocular trauma, and chemical injuries. They help improve eyesight, relieve pain, maintain the proper shape of the cornea, and treat severe infections or damage. They also assist in restoring a clear vision of patients suffering from corneal scarring and corneal diseases and enable them to perform daily activities effortlessly.

Artificial Cornea and Corneal Implant Market Trends:

At present, the increasing demand for artificial cornea and corneal implants due to the rising prevalence of corneal infections and eye-associated disorders among the masses represents one of the primary factors influencing the market positively. Besides this, the growing construction of various healthcare facilities, such as hospitals, nursing homes, and eye clinics, to provide effective treatment to patients is offering a favorable market outlook. In addition, the rising occurrence of eyesight complications among young individuals for spending prolonged hours looking at smartphones or working on computers and laptops is propelling the growth of the market. Apart from this, the increasing demand for full-thickness corneal transplantation due to the rising geriatric population worldwide is contributing to the growth of the market. Additionally, there is a rise in the adoption of minimally invasive (MI) corneal transplantation methods to avoid scarring, fasten the recovery period, and reduce the costs and duration of hospital stays. This, coupled with the increasing preference for penetrating keratoplasty procedures to treat eye-related complications in older patients, is supporting the market growth. Moreover, the rising utilization of various innovative and effective medical products, such as three-dimensional (3D) printed artificial cornea with better biocompatibility and customizability in treating corneal diseases, is strengthening the market growth.

Key Market Segmentation:

Type Insights:

Transplant Type Insights:

Disease Indication Insights:

End User Insights:

Regional Insights:

Competitive Landscape:

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Artificial Cornea and Corneal Implant Market

6 Market Breakup by Type

7 Market Breakup by Transplant Type

8 Market Breakup by Disease Indication

9 Market Breakup by End User

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â